Management of Parkinson's Disease in Geriatric Patients

Critical Geriatric-Specific Concerns

The American Geriatrics Society suggests that clinicians remain vigilant about augmentation risk with long-term dopamine agonist use, although ropinirole itself is not listed on the 2019 Beers Criteria 1, 2
The American Academy of Sleep Medicine guidelines suggest against standard use of ropinirole for RLS due to augmentation concerns, though this applies to RLS treatment specifically rather than Parkinson's disease management 2
If the patient develops REM sleep behavior disorder while on this combination, clonazepam or melatonin may be added, though clonazepam is on the Beers list and requires careful consideration in geriatric patients 3, 4

Regular assessment of nutritional status and vitamin B levels is essential for patients on levodopa, as it causes hyperhomocysteinemia and increases vitamin B requirements 5, 6, 7

Administer carbidopa-levodopa at least 30 minutes before meals to avoid protein interference with levodopa absorption 6, 7
Consider a protein redistribution diet to improve motor function and increase "ON" time, though monitor for weight loss, micronutrient deficiencies, and worsening dyskinesias 6, 7
Separate calcium and iron supplements from carbidopa-levodopa by at least 2 hours to prevent absorption interference 7

Do not assume rigidity is levodopa-resistant without proper dose optimization and timing adjustments, as true levodopa-resistant rigidity is rare 7
Never take carbidopa-levodopa with high-protein meals, as this significantly reduces absorption and may lead to apparent treatment failure 6, 7
Do not overlook vitamin B supplementation needs, as patients on levodopa have demonstrably higher requirements to maintain normal homocysteine levels 5, 6, 7

The onset or worsening of dyskinesias may require reduction in levodopa doses rather than discontinuation of either medication 6